CORCEPT THERAPEUTICS INC Amortization of Intangible Assets
CORCEPT THERAPEUTICS INC (CORT) reported Amortization of Intangible Assets of $52.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2024-05-01
- CORCEPT THERAPEUTICS INC amortization of intangible assets for the quarter ending 2024-03-31 was $52.00K, a 56.30% decline year-over-year.
- CORCEPT THERAPEUTICS INC amortization of intangible assets for the quarter ending 2023-03-31 was $119.00K.
- CORCEPT THERAPEUTICS INC amortization of intangible assets for fiscal 2023 was $465.00K, a 2.52% decline from fiscal 2022.
- CORCEPT THERAPEUTICS INC amortization of intangible assets for fiscal 2022 was $477.00K, a 16.63% increase from fiscal 2021.
- CORCEPT THERAPEUTICS INC amortization of intangible assets for fiscal 2021 was $409.00K.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 12 month |
|---|---|---|
| 2024-03-31 | $52.00K 10-Q · filed 2024-05-01 | |
| 2023-12-31 | $465.00K 10-K · filed 2024-02-15 | |
| 2023-03-31 | $119.00K 10-Q · filed 2024-05-01 | |
| 2022-12-31 | $477.00K 10-K · filed 2024-02-15 | |
| 2021-12-31 | $409.00K 10-K · filed 2024-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |